What does CUSIP 89422G107 represent in this 13F holders report?

CUSIP 89422G107 is the security identifier for TVTX - Travere Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TVTX - Travere Therapeutics, Inc. - Common Stock in Q1 2021?

147 institutional investors reported TVTX - Travere Therapeutics, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Travere Therapeutics, Inc. - Common Stock (TVTX)

CUSIP: 89422G107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 92,326,601
Total 13F shares: 62,621,768
Share change: +10,392,645
Total reported value: $1,563,390,183
Put/Call ratio: 75%
Price per share: $24.97
Number of holders: 147
Value change: +$254,685,025
Number of buys: 92
Number of sells: 58

Quarterly Holders Quick Answers

What is CUSIP 89422G107?
CUSIP 89422G107 identifies TVTX - Travere Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 89422G107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	5.2%	4,825,174	$131,510,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	4.9%	4,557,867	$124,225,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	4.4%	4,083,553	$111,297,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	3.8%	3,493,607	$95,218,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	3.7%	3,404,443	$92,788,000	—	31 Dec 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	3.1%	2,850,000	$77,677,000	—	31 Dec 2020	13F
MACQUARIE GROUP LTD	13F	Company	3%	2,763,922	$75,331,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	2.6%	2,398,633	$65,375,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	2.4%	2,186,830	$59,603,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2%	1,861,422	$50,733,000	—	31 Dec 2020	13F
Avoro Capital Advisors LLC	13F	Company	2%	1,800,500	$49,073,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	1.7%	1,543,842	$42,077,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	1,191,712	$32,481,000	—	31 Dec 2020	13F
Rock Springs Capital Management LP	13F	Company	1.1%	1,021,000	$27,827,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	1%	964,528	$26,288,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.82%	757,852	$20,655,000	—	31 Dec 2020	13F
SCOPIA CAPITAL MANAGEMENT LP	13F	Company	0.8%	741,214	$20,202,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.79%	727,176	$19,819,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.77%	713,966	$19,459,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.82%	761,022	$18,767,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.72%	667,499	$18,193,000	—	31 Dec 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.7%	646,050	$17,608,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.67%	621,000	$16,925,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.67%	614,897	$16,758,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.6%	558,310	$15,217,000	—	31 Dec 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.51%	475,000	$12,946,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.48%	444,281	$12,108,000	—	31 Dec 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.37%	341,282	$9,300,000	—	31 Dec 2020	13F
GW&K Investment Management, LLC	13F	Company	0.35%	324,300	$8,839,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.29%	265,234	$7,229,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.22%	202,333	$5,515,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.21%	195,689	$5,334,000	—	31 Dec 2020	13F
AXA S.A.	13F	Company	0.21%	190,200	$5,184,000	—	31 Dec 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.19%	174,274	$4,784,000	—	31 Dec 2020	13F
THRIVENT FINANCIAL FOR LUTHERANS	13F	Company	0.18%	164,383	$4,481,000	—	31 Dec 2020	13F
Palo Alto Investors LP	13F	Company	0.17%	157,900	$4,304,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.17%	157,600	$4,295,000	—	31 Dec 2020	13F
Polar Capital Holdings Plc	13F	Company	0.14%	125,000	$3,407,000	—	31 Dec 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.13%	122,819	$3,348,000	—	31 Dec 2020	13F
OAK RIDGE INVESTMENTS LLC	13F	Company	0.13%	122,076	$3,327,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.12%	112,147	$3,056,000	—	31 Dec 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.12%	111,864	$3,049,000	—	31 Dec 2020	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.12%	110,604	$3,015,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	109,815	$2,993,000	—	31 Dec 2020	13F
DRW Securities, LLC	13F	Company	0.11%	100,000	$2,726,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.11%	97,800	$2,666,000	—	31 Dec 2020	13F
ALPS ADVISORS INC	13F	Company	0.1%	92,012	$2,508,000	—	31 Dec 2020	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.1%	90,065	$2,455,000	—	31 Dec 2020	13F
Allianz Asset Management GmbH	13F	Company	0.09%	83,620	$2,279,000	—	31 Dec 2020	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.09%	79,528	$2,168,000	—	31 Dec 2020	13F

Institutional Holders of Travere Therapeutics, Inc. - Common Stock (TVTX) as of Q1 2021

As of 31 Mar 2021, Travere Therapeutics, Inc. - Common Stock (TVTX) was held by 147 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,621,768 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, MACQUARIE GROUP LTD, STATE STREET CORP, BANK OF AMERICA CORP /DE/, and ARMISTICE CAPITAL, LLC. This page lists 147 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

135

Q1 2021 holders

147

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.